Related Experiment Video
Updated: Aug 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Fasudil prevents KATP channel-induced improvement in postischemic functional recovery
Kenya Nishizawa1, Paul E Wolkowicz, Tadashi Yamagishi
1Dept. of Medicine, Univ. of Alabama at Birmingham, Birmingham, AL 35294, USA.
Insights
Activation of ATP-dependent potassium (K(ATP)) channels improves heart recovery after ischemia. Rho kinase (ROCK) activity is crucial for this K(ATP) channel-induced cardioprotection, as inhibiting ROCK blocks the beneficial effects.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Cell Signaling
Background:
- ATP-dependent potassium (K(ATP)) channels are known to enhance myocardial recovery post-ischemia.
- The precise molecular mechanisms underlying K(ATP) channel-mediated cardioprotection are not fully understood.
- RhoA, a GTPase, influences cellular processes relevant to K(ATP) channel function.
Purpose of the Study:
- To investigate whether rho kinase (ROCK), a key effector of RhoA, is essential for K(ATP) channel-induced cardioprotection.
- To elucidate the role of ROCK in the beneficial effects of K(ATP) channel activation on the ischemic heart.
Main Methods:
- Utilized isolated perfused rat hearts subjected to a model of ischemia-reperfusion.
- Compared mechanical function and high-energy phosphate levels ((31)P NMR) across four experimental groups: untreated, K(ATP) channel activation (pinacidil), ROCK inhibition (fasudil), and combined treatment.
- Administered pinacidil to activate K(ATP) channels and fasudil to inhibit ROCK.
Main Results:
- Pinacidil treatment significantly improved post-ischemic mechanical recovery, indicated by increased left ventricular diastolic pressure (LVDP).
- Fasudil alone did not alter reperfusion LVDP but completely abolished the protective effects of pinacidil.
- ROCK inhibition also led to substantial attenuation of post-ischemic energetic recovery.
Conclusions:
- Rho kinase (ROCK) activity is a necessary component for K(ATP) channel-induced cardioprotection.
- These findings support the hypothesis that ROCK signaling plays a critical role in mediating the beneficial effects of K(ATP) channel activation on the heart during and after ischemia.
Abstract:
Whereas activation of ATP-dependent potassium (K(ATP)) channels greatly improves postischemic myocardial recovery, the final effector mechanism for K(ATP) channel-induced cardioprotection remains elusive. RhoA is a GTPase that regulates a variety of cellular processes known to be involved with K(ATP) channel cardioprotection. Our goal was to determine whether the activity of a key rhoA effector, rho kinase (ROCK), is required for K(ATP) channel-induced cardioprotection. Four groups of perfused rat hearts were subjected to 36 min of zero-flow ischemia and 44 min of reperfusion with continuous measurements of mechanical function and (31)P NMR high-energy phosphate data: 1) untreated, 2) pinacidil (10 microM) to activate K(ATP) channels, 3) fasudil (15 microM) to inhibit ROCK, and 4) both fasudil and pinacidil. Pinacidil significantly improved postischemic mechanical recovery [39 +/- 16 vs. 108 +/- 4 mmHg left ventricular diastolic pressure (LVDP), untreated and pinacidil, respectively]. Fasudil did not affect reperfusion LVDP (41 +/- 13 mmHg) but completely blocked the marked improvement in mechanical recovery that occurred with pinacidil treatment (54 +/- 15 mmHg). Substantial attenuation of the postischemic energetic recovery was also observed. These data support the hypothesis that ROCK activity plays a role in K(ATP) channel-induced cardioprotection.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

